| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.DRUDIS.2006.08.009 |
| P698 | PubMed publication ID | 16997142 |
| P50 | author | Reposo Ramírez-Lorca | Q67214099 |
| Agustín Ruíz | Q79248373 | ||
| P2093 | author name string | Francisco J Moron | |
| Maria E Saez | |||
| P433 | issue | 19-20 | |
| P304 | page(s) | 917-923 | |
| P577 | publication date | 2006-09-07 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | The therapeutic potential of the calpain family: new aspects | |
| P478 | volume | 11 |
| Q41814857 | A novel strategy for therapeutic intervention for the genetic disease: preventing proteolytic cleavage using small chemical compound |
| Q42940298 | Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis. |
| Q36314816 | Affinity purification of human m-calpain through an intrinsically disordered inhibitor, calpastatin |
| Q38268518 | An updated patent review of calpain inhibitors (2012 - 2014). |
| Q42012880 | Beneficial effects of antecedent exercise training on limb motor function and calpain expression in a rat model of stroke |
| Q34349686 | CalpB modulates border cell migration in Drosophila egg chambers |
| Q89823912 | Calpain Small Subunit 1 Protein in the Prognosis of Cancer Survivors and Its Clinicopathological Correlation |
| Q37502232 | Calpain and the glutamatergic synapse |
| Q46442267 | Calpain inhibitors alter the excitable membrane properties of cultured aplysia neurons |
| Q37857282 | Calpain inhibitors: a survey of compounds reported in the patent and scientific literature |
| Q39723688 | Calpain plays a central role in 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in cerebellar granule neurons. |
| Q21261445 | Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels |
| Q37237452 | Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration |
| Q34272471 | Calpains: potential targets for alternative chemotherapeutic intervention against human pathogenic trypanosomatids |
| Q37716754 | Calpastatin Overexpression Preserves Cognitive Function Following Seizures, While Maintaining Post-Injury Neurogenesis. |
| Q98298094 | Capn4 contributes to tumor invasion and metastasis in gastric cancer via activation of the Wnt/β-catenin/MMP9 signalling pathways |
| Q49241232 | Capn4 overexpression indicates poor prognosis of ovarian cancer patients |
| Q93168989 | Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/β-catenin signaling pathway |
| Q36153375 | Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2. |
| Q39729500 | Cell death induced by Bothrops asper snake venom metalloproteinase on endothelial and other cell lines. |
| Q35660362 | Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy |
| Q47165501 | Co-conspirators in a new mechanism for the degradation of Δ9-desaturase |
| Q27652953 | Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains |
| Q37581981 | Critical role of calpain in inflammation |
| Q48769291 | Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain |
| Q37369066 | Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease |
| Q38010378 | High molecular weight calmodulin-binding protein: 20 years onwards-a potential therapeutic calpain inhibitor |
| Q33755662 | Homology modeling study of bovine μ-calpain inhibitor-binding domains. |
| Q34202768 | Incorporation of noncanonical amino acids into Rosetta and use in computational protein-peptide interface design |
| Q39015599 | Increased expression of Capn4 is associated with the malignancy of human glioma. |
| Q41877726 | Inhibition of calpain but not caspase activity by spectrin fragments |
| Q37616206 | Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection |
| Q36856535 | Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity. |
| Q35148702 | Mechanism of action of thalassospiramides, a new class of calpain inhibitors |
| Q48365341 | Memantine attenuates cell apoptosis by suppressing the calpain-caspase-3 pathway in an experimental model of ischemic stroke |
| Q36582810 | Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species |
| Q30485868 | Neurite consolidation is an active process requiring constant repression of protrusive activity |
| Q44235258 | New m-calpain substrate-based azapeptide inhibitors |
| Q34563366 | Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma |
| Q33855223 | Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation |
| Q94452440 | Protective role of endothelial calpain knockout in lipopolysaccharide-induced acute kidney injury via attenuation of the p38-iNOS pathway and NO/ROS production |
| Q38884495 | RPF151, a novel capsaicin-like analogue: in vitro studies and in vivo preclinical antitumor evaluation in a breast cancer model |
| Q35219135 | Regulation of the calpain and ubiquitin-proteasome systems in a canine model of muscular dystrophy. |
| Q33307877 | Role of proteasomes in disease |
| Q58035473 | Synthesis of a 24-Membered Cyclic Peptide-Biphenyl Hybrid |
| Q97522239 | Targeted inhibition of endothelial calpain delays wound healing by reducing inflammation and angiogenesis |
| Q27335461 | Targeted proteolysis of plectin isoform 1a accounts for hemidesmosome dysfunction in mice mimicking the dominant skin blistering disease EBS-Ogna |
| Q40839491 | Targeting host calpain proteases decreases influenza A virus infection. |
| Q37215861 | Tau-based treatment strategies in neurodegenerative diseases |
| Q33359090 | Understanding the interaction determinants of CAPN1 inhibition by CAST4 from bovines using molecular modeling techniques. |
| Q42130947 | Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis? |
Search more.